1. Home
  2. BIO vs CHE Comparison

BIO vs CHE Comparison

Compare BIO & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$285.94

Market Cap

6.9B

Sector

Industrials

ML Signal

HOLD

CHE

Chemed Corp

HOLD

Current Price

$419.31

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
CHE
Founded
1952
1970
Country
United States
United States
Employees
7450
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical/Nursing Services
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
5.8B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
BIO
CHE
Price
$285.94
$419.31
Analyst Decision
Buy
Buy
Analyst Count
4
4
Target Price
$339.75
$501.50
AVG Volume (30 Days)
431.5K
187.2K
Earning Date
04-30-2026
04-23-2026
Dividend Yield
N/A
0.57%
EPS Growth
N/A
N/A
EPS
N/A
4.84
Revenue
N/A
$2,529,978,000.00
Revenue This Year
$2.74
$6.56
Revenue Next Year
$3.20
$6.23
P/E Ratio
$9.72
$86.96
Revenue Growth
N/A
4.06
52 Week Low
$222.80
$365.21
52 Week High
$343.12
$562.77

Technical Indicators

Market Signals
Indicator
BIO
CHE
Relative Strength Index (RSI) 47.20 44.86
Support Level $256.85 $419.30
Resistance Level $288.48 $453.11
Average True Range (ATR) 9.54 12.65
MACD -2.00 -2.34
Stochastic Oscillator 1.12 14.36

Price Performance

Historical Comparison
BIO
CHE

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CHE Chemed Corp

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Share on Social Networks: